Long-Term (>10 Years) Clinical Outcomes of First-In-Man Biodegradable Poly-l-lactic Acid Coronary Stents: Igaki-Tamai Stents Running title: Nishio et al.; First-in-man biodegradable PLLA coronary stent
نویسندگان
چکیده
Soji Nishio, MD; Kunihiko Kosuga, MD, PhD, FJCC; Keiji Igaki, PhD; Masaharu Okada, MD, PhD; Eisho Kyo, MD; Takafumi Tsuji, MD; Eiji Takeuchi, MD, PhD; Yasutaka Inuzuka, MD, PhD; Shinsaku Takeda, MD; Tatsuhiko Hata, MD, PhD; Yuzo Takeuchi, MD, PhD; Yoshitaka Kawada, MD; Takeshi Harita, MD; Junya Seki, MD; Shunji Akamatsu, ME; Shinichi Hasegawa, ME; Nico Bruining, PhD; Salvatore Brugaletta, MD; Sebastiaan de Winter, BSc; Takashi Muramatsu, MD; Yoshinobu Onuma, MD; Patrick W. Serruys, MD, PhD; Shigeru Ikeguchi, MD, PhD
منابع مشابه
Decade of histological follow-up for a fully biodegradable poly-L-lactic acid coronary stent (Igaki-Tamai stent) in humans: are bioresorbable scaffolds the answer?
A n 83-year-old male with a history of angina pecto-ris presented with massive intracranial hemorrhage in June 2011, and he died 2 days after admission. Previously, he was included in the first inhuman feasibility study of biodegradable poly-l-lactic acid (PLLA) coronary stents: the To assess the long-term behavior of PLLA coronary stents in humans, postmortem examination of his coronary arteri...
متن کاملInitial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans.
BACKGROUND Although metallic stents are effective in preventing acute occlusion and reducing late restenosis after coronary angioplasty, many concerns still remain. Compared with metallic stents, poly-l-lactic acid (PLLA) stents are biodegradable and can deliver drugs locally. The aim of this study was to evaluate the feasibility, safety, and efficacy of the PLLA stent. METHODS AND RESULTS Fi...
متن کاملIntramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo.
OBJECTIVES This study was designed to examine whether or not intramural delivery of ST638 (a specific tyrosine kinase inhibitor) with biodegradable stent can suppress the restenotic changes of the coronary artery in vivo. BACKGROUND Clinical and animal studies demonstrated that restenosis after coronary intervention results from a combined effect of neointimal formation and geometric remodeli...
متن کاملBioresorbable vascular scaffold: promises and the fallen child-as-king?
Correspondence to Stéphane Cook; [email protected] THE BIORESORBABLE VASCULAR SCAFFOLDS ‘BVS’ The main limitation of percutaneous coronary intervention compared to open-heart surgery is the insertion of a foreign body (usually a stent) inside the coronary artery. This is associated with foreign body inflammation that triggers restenosis, neoatherosclerosis and late-occurring stent thrombos...
متن کاملDevelopment of a New Hybrid Biodegradable Drug-Eluting Stent for the Treatment of Peripheral Artery Disease
This study aimed to develop a new biodegradable stent for peripheral artery disease (PAD) that could provide sufficient radial force to maintain long-term patency and flexibility. All self-expandable hybrid biodegradable stents were designed by using a knitting structure composed of poly-L-lactic acid (PLLA) and nitinol. Four different types of stents were implanted in 20 iliac arteries in 10 m...
متن کامل